From Discovery R&D Milligrams to Clinical GMP Kilograms
Icosagen Cell Factory is a specialized and independent European mammalian protein drug discovery, development, and manufacturing expert, and uniquely combines CRO and CDMO capabilities under one roof, to offer fully integrated CRDMO services.
Icosagen built its own, state-of-the-art, on site GMP manufacturing plant with 50L, 200L and 1000L single-use bioreactors. With the latest facility upgrade to right beside our existing premises, our partners can now seamlessly transition their antibody and recombinant protein drug candidates on site from research concept into preclinical stage and right into GMP manufactured Phase I/II clinical trials material supplies.
The brand-new facility is designed and constructed for high-throughput biologics GMP manufacturing. It is outfitted with the latest single-use equipment for the production of bulk drug substance, housing QC & QA, GMP cell banking, seed train, upstream and downstream suites in one 1400 m² building e. g. for EMA and FDA-approved clinical trials materials.
SEAMLESS TRANSITION
SEAMLESS TRANSITION
From discovery to large scale production.
FAST in vivo APPROACH
FAST in vivo APPROACH
After immunization stage, biologically active antibodies with optimal physicochemical properties can be delivered as fast as 8 to 9 weeks.
IMMUNIZATION AGILITY
IMMUNIZATION AGILITY
Immunization of chickens with DNA, peptides, proteins or VLPs can be used to develop antibodies against hard-to-express proteins.
FLEXIBLE
FLEXIBLE
All identified sequences can be used for production of different immune molecules (bi-specifics, chimeras, antibody fragmens etc.)